Biocept entered into a supply agreement with Aegea Biotechnologies for a new PCR-based Covid-19 assay kit. Shares of Biocept fell 1.
It has been three weeks since the coronavirus-driven volatility hit the global economy, and the market continues to rapidly move into both the …
In the biotech-verse, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Biocept Inc (NASDAQ:BIOC) are in opposite standing. According to one of the best analysts …
Biocept Inc (NASDAQ:BIOC) investors celebrate a 60% gain in the stock after the molecular diagnostics company announced that it has secured an in-network provider …
Biocept Inc (NASDAQ:BIOC) investors are having a rough morning after the cancer diagnostic test maker announced that it intends to offer and sell 9,100,000 shares of its …
Biocept Inc (NASDAQ:BIOC), a molecular diagnostics company commercializing and developing blood-based liquid biopsies to provide information to physicians to improve the diagnosis and …
Yesterday, Biocept Inc (NASDAQ:BIOC) announced news of solidifying a new agreement with Teneovita Medical Innovations for a full distribution range of liquid biopsy testing …
Biocept Inc (NASDAQ:BIOC), a molecular diagnostics company commercializing and developing assays for liquid biopsies to improve the detection and treatment of cancer, announces an …
Biocept Inc (NASDAQ:BIOC), a molecular diagnostics company commercializing and developing liquid biopsies to improve the detection and treatment of cancer, announces that it …
Biocept Inc (NASDAQ:BIOC), a molecular diagnostics company commercializing and developing assays for liquid biopsies to improve the detection and treatment of cancer, announces …
